ACADIAN ASSET MANAGEMENT LLC - CYCLACEL PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of CYCLACEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$124
-41.0%
363,3670.0%0.00%0.0%
Q2 2023$210
+1.9%
363,3670.0%0.00%0.0%
Q1 2023$206
-14.2%
363,3670.0%0.00%0.0%
Q4 2022$240
-100.0%
363,367
-1.1%
0.00%
-66.7%
Q3 2022$535,000
+643.1%
367,477
+449.3%
0.00%
Q2 2022$72,000
+3500.0%
66,900
+8315.1%
0.00%
Q1 2022$2,000
-97.8%
795
-96.6%
0.00%
Q4 2021$89,000
+134.2%
23,242
+257.5%
0.00%
Q2 2021$38,000
-84.3%
6,502
-80.9%
0.00%
-100.0%
Q1 2021$242,000
+4.8%
34,057
-31.5%
0.00%0.0%
Q2 2020$231,00049,7070.00%
Other shareholders
CYCLACEL PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 250,000$166,7500.04%
McIlrath & Eck, LLC 26,342$17,5700.01%
Schonfeld Strategic Advisors LLC 770,400$513,8570.00%
Virtu Financial LLC 23,793$160.00%
ACADIAN ASSET MANAGEMENT LLC 363,367$2400.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 64,068$42,7330.00%
CONDOR CAPITAL MANAGEMENT 10,000$6,6700.00%
Point72 Asset Management, L.P. 230,000$153,4100.00%
Ergoteles LLC 25,976$17,3260.00%
BlackRock Inc. 4,697$3,1320.00%
View complete list of CYCLACEL PHARMACEUTICALS INC shareholders